Today is 2019-03-21

Trial search
Filter Options
Public title Scientific title Subject ID
Registration Status Registration number Secondary ID
       More Options

18 trials have been registered

Historical versions Registration number Public title Type Registration time
Historical Versions ChiCTR1900021059

G-CSF priming and cladribine plus cytarabine included conditioning regimen in hematopoetic transplantation of high risk or refractory acute leukemia

Xin Qiao hospital

Interventional 2019/01/27
Historical Versions ChiCTR1800020344

One-arm, two-stage clinical study for cladribine combined with G-CSF, low-dose cytarabine and peminase (C-GAP) in the treatment of relapsed refractory acute lymphoblastic leukemia/lymphocytic lymphoma

Department of Hematology, Cancer Center, Sun Yat-sen University

Observational 2018/12/25
Historical Versions ChiCTR1800017569

Clinical trial of cladribine combined with cytarabine and liposomal doxorubicin in remission induction of high-risk or refractory acute myeloid leukemia

Xinqiao Hospital

  2018/08/04
Historical Versions ChiCTR1800017310

A randomized controlled trial for arsenic trioxide combined with ESHAP (etoposide+methylprednisolone+cytarabine+cisplatin) in the treatment of relapsed or refractory ALK+ anaplastic large cell lymphoma.

Tongji Hospital Affiliated to Tongji University School of Medicine

Interventional 2018/07/23
Historical Versions ChiCTR1800015922

A randomized multicenter clinical trial of medium dose cytarabine based CEAC regimen combined with cratripine preconditioning in the treatment of high-risk NHL

The Second Affiliated Hospital of Army Medical University

Interventional 2018/04/29
Historical Versions ChiCTR1800015871

A clinical study of chidamide with FLAG (fludarabine+cytarabine+G-CSF) in the treatment of relapsed /refractory /first cycle induced non-remission acute myeloid leukemia

Anhui Provincial Hospital

  2018/04/25
Historical Versions ChiCTR1800014975

High dose cytarabine plus temozolomide for refractory/relapsed primary diffuse large B cell lymphoma of central nervous system: a prospective clinical study

North Huashan Hospital, Fudan University

Observational 2018/02/25
Historical Versions ChiCTR-INR-17012015

Evaluation of the efficacy and safety of single-dose PEG-rhG-CSF, cytarabine and aclaramycin regimens for relapse or refractory acute myeloid leukemia

Xinqiao Hospital, Chongqing

Interventional 2017/05/31
Historical Versions ChiCTR-OPC-16010166

Efficacy and safety of cladribine in combination with G-CSF, low-dose cytarabine and aclarubicin in patients with refractory/relapsed acute myeloid leukemia: a phase 2, single center, single arm study

Sun Yat-sen University Cancer Center

Observational 2016/12/15
Historical Versions ChiCTR-OIC-15007583

Efficacy and safety of cladribine in combination with G-CSF, low-dose cytarabine and aclarubicin in newly diagnosed elderly patients with acute myeloid leukemia: a phase 2, single center, single arm study

Sun Yat-sen University Cancer Center

Observational 2015/12/16
First 1 2 Next Last